Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
Read More Pharma Industry News Can Mycenax’s ADC linker license deal with RIN boost Taiwan’s global CDMO standing? Find out how Mycenax Biotech Inc. is reshaping Taiwan’s ADC CDMO positioning through a global linker technology license deal with Japan’s RIN Institute. byVenkateshOctober 31, 2025